在复杂的穿皮冠状动脉干预中进行抗血栓治疗.
Domenico Simone Castiello1, Angelo Oliva2, Giuseppe Andò3
1Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
概括
在复杂的穿皮冠状动脉干预 (PCI) 后,优化抗血栓治疗至关重要. 根据患者个人资料和PCI复杂性量身定制治疗平衡缺血风险和出血风险,以获得更好的结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 穿皮冠状动脉干预 (PCI) 是晚期冠状动脉疾病的主要治疗方法.
- 抗血栓治疗对于预防PCI后缺血事件至关重要.
- 复杂的PCI由于增加出血风险而带来挑战.
研究的目的:
- 审查复杂的PCI后对抗血栓治疗的现有证据.
- 根据患者和程序因素指导个性化的抗血栓策略.
- 在特定复杂的PCI场景中解决最佳处理.
主要方法:
- 对复杂的PCI中抗血栓治疗的现有文献进行系统审查.
- 对双重抗血小板治疗,P2Y12抑制剂单一治疗和双重途径抑制的数据分析.
- 在特定的患者群体和复杂的解剖学中讨论抗血栓治疗.
主要成果:
- 没有单一的抗血栓治疗方案适合所有接受复杂PCI的患者.
- 风险分层是平衡缺血和出血风险的关键.
- 长期DAPT,P2Y12单疗法和双通道抑制等特定方法显示出有前途.
结论:
- 复杂的PCI需要个性化的抗血栓策略.
- 需要进一步的研究来完善最佳的抗血栓治疗方案.
- 仔细考虑患者特异性因素和PCI复杂性至关重要.
相关概念视频
Venous Thrombosis III: Interprofessional Care
280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
Acute Coronary Syndrome IV: Interprofessional Care
220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
Peripheral Artery Disease III: Interprofessional Care
248
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
248
Coronary Artery Disease V: Interprofessional Care
215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
329
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
329
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K


